Scancell (LON:SCLP) Trading Up 16.8% - Here's What Happened

Scancell Holdings plc (LON:SCLP - Get Free Report)'s share price rose 16.8% on Monday . The stock traded as high as GBX 10.24 ($0.14) and last traded at GBX 9.90 ($0.13). Approximately 6,577,034 shares traded hands during mid-day trading, an increase of 680% from the average daily volume of 843,731 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Up 5.5 %

The stock's fifty day simple moving average is GBX 8.58 and its 200-day simple moving average is GBX 10.80. The stock has a market cap of £109.27 million, a P/E ratio of -16.18 and a beta of 0.35. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.

Scancell (LON:SCLP - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. As a group, research analysts forecast that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

About Scancell

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.